STRATA Skin Sciences, a medical technology company, concluded a registered direct offering issuing 1,097,547 shares at $2.204 per share.
The offering was facilitated by Ladenburg Thalmann & Co. Inc.
The company intends to utilize the net proceeds for working capital and general corporate purposes.
Registered Direct Offering
1,097,547 shares of common stock issued at a per share price of $2.204.
Proceed Allocation
Net proceeds of approximately $2.42 million are earmarked for working capital and general corporate uses.
Placement Agent
Ladenburg Thalmann & Co. Inc. served as the exclusive placement agent for the offering.
- STRATA Skin Sciences strengthens its financial position with proceeds from the offering.
- The capital infusion will support the company's operational activities and strategic initiatives.
The successful closure of the offering enhances STRATA Skin Sciences' financial stability and operational capabilities, positioning the company for growth and innovation in the medical technology sector.